Lansoprazole Dr

Indications

Lansoprazole delayed-release capsules are proton pump inhibitors (PPIs) indicated for the: • Treatment of active duodenal ulcer in adults. (1.1) • Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. (1.2) • Maintenance of healed duodenal ulcers in adults. (1.3) • Treatment of active benign gastric ulcer in adults. (1.4) • Healing of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. (1.5) • Risk reduction of NSAID-associated gastric ulcer in adults. (1.6) • Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older. (1.7) • Treatment of erosive esophagitis (EE) in adults and pediatric patients 1 year of age and older. (1.8) • Maintenance of healing of EE in adults. (1.9) • Pathological hypersecretory conditions, including Zollinger-Ellison syndrome (ZES) in adults. (1.10)